Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: unknown

Published: March 6, 2025

The development of a long-acting neuromuscular blocking agent and its on-demand reversal is highly desired for prolonged surgeries. This viewpoint discussed the discovery supramolecular partners, an imidazolium-based macrocycle (YW70271) acyclic cucurbit[n]uril (WY22051), ultralong blockade rapid reversal.

Language: Английский